Literature DB >> 15988406

Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001.

.   

Abstract

Smoking harms nearly every organ of the body, causing many diseases and reducing quality of life and life expectancy. This report assesses the health consequences and productivity losses attributable to smoking in the United States during 1997-2001. CDC calculated national estimates of annual smoking-attributable mortality (SAM), years of potential life lost (YPLL) for adults and infants, and productivity losses for adults. The findings indicated that, during 1997-2001, cigarette smoking and exposure to tobacco smoke resulted in approximately 438,000 premature deaths in the United States, 5.5 million YPLL, and 92 billion dollars in productivity losses annually. Implementation of comprehensive tobacco-control programs as recommended by CDC can reduce smoking prevalence and related mortality and health-care costs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988406

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  234 in total

1.  Smoking cessation quitlines: an underrecognized intervention success story.

Authors:  Edward Lichtenstein; Shu-Hong Zhu; Gary J Tedeschi
Journal:  Am Psychol       Date:  2010 May-Jun

Review 2.  Genetics of smoking and depression.

Authors:  Ming T Tsuang; Tracee Francis; Kyle Minor; Alison Thomas; William S Stone
Journal:  Hum Genet       Date:  2012-04-17       Impact factor: 4.132

3.  Attention deficit/hyperactivity disorder symptoms and depression symptoms as mediators in the intergenerational transmission of smoking.

Authors:  Alex Zoloto; Craig T Nagoshi; Clark Presson; Laurie Chassin
Journal:  Drug Alcohol Depend       Date:  2012-06-08       Impact factor: 4.492

4.  Prefrontal-striatal pathway underlies cognitive regulation of craving.

Authors:  Hedy Kober; Peter Mende-Siedlecki; Ethan F Kross; Jochen Weber; Walter Mischel; Carl L Hart; Kevin N Ochsner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  Evaluation of an online tobacco cessation course for health professions students.

Authors:  Andrew N Schmelz; Brandon Nixon; Anna McDaniel; Karen Suchanek Hudmon; Alan J Zillich
Journal:  Am J Pharm Educ       Date:  2010-03-10       Impact factor: 2.047

Review 6.  Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor.

Authors:  Wen-Yan Cui; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

Review 7.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 8.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

9.  Predictors of smoking cessation counseling adherence in a socioeconomically disadvantaged sample of pregnant women.

Authors:  Kuang-Yi Wen; Suzanne M Miller; Amy Lazev; Zhu Fang; Enrique Hernandez
Journal:  J Health Care Poor Underserved       Date:  2012-08

10.  Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments.

Authors:  Hedy Kober; Judson A Brewer; Keri L Height; Rajita Sinha
Journal:  Neuroimage       Date:  2016-09-28       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.